Acorda Therapeutics, Inc. (ACOR)
(Delayed Data from NSDQ)
$11.74 USD
+1.16 (10.96%)
Updated May 3, 2019 04:00 PM ET
After-Market: $11.74 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMEarnings News For ACOR
-
Acorda: Q3 Earnings Snapshot
-
Acorda Therapeutics Reports Third Quarter 2023 Financial Results
-
Acorda: Q2 Earnings Snapshot
-
Acorda Therapeutics Reports Second Quarter 2023 Financial Results
-
Acorda: Q1 Earnings Snapshot
-
Acorda Therapeutics Reports First Quarter 2023 Financial Results
-
Acorda: Q4 Earnings Snapshot
-
Acorda Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
-
Acorda: Q3 Earnings Snapshot
-
Acorda Therapeutics Reports Third Quarter 2022 Financial Results
-
Acorda: Q2 Earnings Snapshot
-
Acorda Therapeutics Reports Second Quarter 2022 Financial Results
-
Acorda Therapeutics (ACOR) Reports Q2 Loss, Tops Revenue Estimates
-
Will Acorda Therapeutics (ACOR) Report Negative Q2 Earnings? What You Should Know
-
Acorda Therapeutics (ACOR) Reports Q1 Loss, Tops Revenue Estimates
-
Acorda Therapeutics (ACOR) Reports Q4 Loss, Tops Revenue Estimates
-
Acorda (ACOR) to Report Q4 Earnings: What's in the Cards?
-
Acorda Therapeutics (ACOR) Reports Q3 Loss, Tops Revenue Estimates
-
Acorda Therapeutics (ACOR) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
-
Acorda Therapeutics (ACOR) Reports Q2 Loss, Tops Revenue Estimates
-
Acorda (ACOR) Down 11.8% Since Last Earnings Report: Can It Rebound?
-
Acorda (ACOR) Q1 Earnings Lag Estimates, Revenues Fall Y/Y
-
Acorda Therapeutics (ACOR) Reports Q1 Loss, Misses Revenue Estimates
-
Acorda (ACOR) to Report Q1 Earnings: What's in the Cards?
-
Why Is Acorda (ACOR) Down 54.7% Since Last Earnings Report?